New study to explore the health and socio-economic factors impacting cancer patient outcomes

March 31, 2017

RESEARCH TRIANGLE PARK, NC -- How do health and socio-economic factors impact the nearly 1.7 million people diagnosed with cancer each year? RTI International plans to explore this through a new Robert Wood Johnson Foundation grant.

The grant is supporting a collaborative effort to integrate socio-economic data with the Project Data Sphere, LLC (PDS) -- an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium. PDS provides data scientists with no-cost access to cancer trial data and sophisticated analytics software tools.

PDS contains patient information from more than 70 trials, but this information is not complete. The system contains only data related to the clinical trial and does not include information on socio-economic status or medical history, nor comprehensive information on other health. For example, in a clinical trial on prostate cancer, the study data would include information on tumor sizes and drugs used to treat the cancer. It does not comprehensively show how socio-economic factors or other health concerns may have played a role in the treatment.

Patients with lower socio-economic status typically suffer from multiple health concerns, such as obesity and diabetes. And they often have reduced or limited access to care, meaning their treatments begin later. These intervening factors can affect how patients respond to new treatments. By integrating this information with clinical trial data, researchers can gain a broader sense of the effectiveness of a cancer intervention and have a greater ability to predict how socio-economic factors and other health concerns affect various treatments.

"Through this project, we're providing a way to bring a broader perspective to cancer clinical trial data, which enhances the analytic capacity of Project Data Sphere with nationally representative healthcare data that does not typically characterize a controlled study," said Steve Cohen, Ph.D., vice president for RTI's Division of Statistical and Data Sciences.

RTI researchers will integrate information from the Medical Expenditure Panel Survey (MEPS)--a national survey that contains information on families and individuals, and their medical providers--into selected data sets hosted on PDS.

To marry the two data sets, researchers will use a variety of advanced statistical methods, including RTI's Model-Assisted Data Integration System, which is designed to append variables to datasets in a statistically principled manner that allows researchers to quantify uncertainty. The work will include matching data by simulating probability distributions of datasets within PDS and MEPS. Throughout the process, researchers will pay particular attention to ensuring confidentiality provisions of both data sources are maintained.

"This is ground-breaking research," said Dr. Martin J. Murphy, chief executive officer of the CEO Roundtable on Cancer. "This study will not only shed new light on the socio-economic circumstances of cancer patients in clinical trials, but also it will help speed the development of new cancer fighting drugs, bringing life-lengthening benefits to both those who join clinical trials, as well as for countless other cancer patients."

The research will continue through the fall of 2017.
-end-


RTI International

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.